Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System
This study has been completed.
Study NCT00614029   Information provided by Zogenix, Inc.

First Received on January 7, 2008.   Last Updated on November 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pharmacokinetics
Bioequivalence
Interventions listed in this trial
Sumatriptan (via Intraject System)
Additional drug interventions recognized in this trial
Sumatriptan
More general drug interventions related to this trial
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin 5-HT1 Receptor Agonists
Serotonin Agents
Serotonin Receptor Agonists
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Zogenix, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services